A Phase 1 Study of Navlimetostat Tablet Formulations

Clinical trial NCT07544628 · RECRUITING

Trial details

NCT number: NCT07544628
Sponsor: Bristol-Myers Squibb
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Participants

Start date: 2026-04-27
Primary completion: 2026-08-31
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.